Advancing promising results from Pillar II collaborative research through the innovation journey

{
  "url": [
    "https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-BRIDGING-2027-02-05"
  ],
  "tags": [
    "STEP-Biotech",
    "STEP-Digital/deep tech",
    "STEP-Cleantech"
  ],
  "type": [
    "1"
  ],
  "links": [
    "[{\"callIdentifier\":\"HORIZON-BRIDGING-2027-02\",\"criterionCode\":\"HORIZON-IA\",\"criterionDescription\":\"HORIZON Innovation Actions\",\"url\":\"https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/47009?topic\\u003dHORIZON-BRIDGING-2027-02-05\",\"startDate\":\"1792454400000\",\"endDate\":\"1801094400000\",\"mgaDescription\":\"HORIZON Lump Sum Grant\",\"mgaCode\":\"HORIZON-AG-LS\"}]"
  ],
  "title": [
    "Advancing promising results from Pillar II collaborative research through the innovation journey"
  ],
  "ccm2Id": [
    "52663814"
  ],
  "status": [
    "31094502"
  ],
  "actions": [
    "[{\"types\":[{\"typeOfAction\":\"HORIZON-IA HORIZON Innovation Actions\",\"typeOfMGA\":[{\"id\":43027849,\"abbreviation\":\"HORIZON-AG-LS\",\"description\":\"HORIZON Lump Sum Grant\"}]}],\"status\":{\"id\":31094502,\"abbreviation\":\"Open\",\"description\":\"Open\"},\"plannedOpeningDate\":\"2026-10-20\",\"submissionProcedure\":{\"id\":31094504,\"abbreviation\":\"single-stage\",\"description\":\"single-stage\"},\"deadlineDates\":[\"2027-01-28\"]}]"
  ],
  "esST_URL": [
    "https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-BRIDGING-2027-02-05"
  ],
  "keywords": [
    "HORIZON-BRIDGING-2027-02-05",
    "HORIZON-BRIDGING-2027-02",
    "Aeronautics",
    "Agricultural biotechnology",
    "Agricultural engineering, food safety",
    "Agriculture related to crop production, soil biology and cultivation, applied plant biology",
    "Agriculture, Forestry, and Fisheries",
    "Agro-forestry",
    "Agroecology",
    "Agroindustry",
    "Agronomy",
    "Alternative fuels",
    "Animal and Dairy science",
    "Animal health",
    "Architecture, smart buildings, smart cities, urban engineering",
    "Artificial intelligence",
    "Arts (arts, history of arts, performing arts, music)",
    "Audiovisual Festivals / Events / Markets / Training - Media",
    "Audiovisual and media",
    "Automation",
    "Automation and control systems",
    "Automation, Telepresence & Robotics",
    "Aviation",
    "BTT5 unmanned aircraft (Drone)",
    "Basic medicine",
    "Behavioural sciences",
    "Big data",
    "Bio-based products (products that are manufactured using biological material as feedstock) bio-based materials, bio-based plastics, biofuels, bio-based and bio-derived bulk and fine chemicals, bio-based and bio-derived novel materials",
    "Biodiversity conservation",
    "Bioeconomy",
    "Biofuels",
    "Biological sciences",
    "Biomedical engineering",
    "Biotechnologies",
    "Biotechnology",
    "Blue Bioeconomy",
    "Border and external security",
    "Business management",
    "Cardiovascular system",
    "Chemical engineering",
    "Chemical sciences",
    "Civil engineering",
    "Climate change adaptation",
    "Clinical medicine",
    "Clinical research",
    "Clinical trials",
    "Cloud, Edge and Virtualisation",
    "Communication technology, high-frequency technology",
    "Computer and information sciences",
    "Computer sciences, information science and bioinformatics",
    "Control and track cross border goods and materials",
    "Critical Infrastructure Protection (CIP)",
    "Cultural and creative economy",
    "Cultural heritage - Culture",
    "Cultural heritage, cultural memory",
    "Cybersecurity",
    "Cybersecurity Research Domains ",
    "Data analytics technologies",
    "Decarbonisation",
    "Democratic engagement and civic participation",
    "Design and applied arts - Culture",
    "Diagnostic and implantable devices, environmental monitoring",
    "Digital Services and Platforms",
    "Digital technonlogies and deep tech innovations",
    "Digital twins",
    "Digitalisation/ICT and cultural heritage",
    "Disaster resilience and crisis management",
    "Disease prevention",
    "EME Electronics & Microelectronics for on-board systems",
    "Earth Observation / Services and applications",
    "Earth and related environmental sciences",
    "Ecological intensification",
    "Economics and Business",
    "Ecosystem-Based Approach",
    "Educational sciences",
    "Electrical and electronic engineering: semiconductors, components, systems",
    "Electrical engineering, Electronic engineering, Information engineering",
    "Electronics, photonics",
    "Emerging Epidemics",
    "End-users",
    "Endocrinology and metabolism (including diabetes, hormones)",
    "Energy",
    "Energy Efficiency",
    "Energy systems (production, distribution, application)",
    "Energy systems, smart energy, smart grids, wireless energy transfer",
    "Environmental biotechnology",
    "Environmental biotechnology, bioremediation, biodegradation",
    "Environmental engineering",
    "Environmental health",
    "Environmental monitoring systems",
    "European Railway Traffic Management System (ERTMS)",
    "Farm machinery",
    "Fertilisation",
    "Fight against crime and terrorism",
    "Financial & Investment management",
    "Fishery",
    "Food and drink processing",
    "Food biotechnology",
    "Food crops",
    "Forest resilience",
    "Forestry",
    "GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming",
    "Gastroenterology and hepatology",
    "Gene therapy, cell therapy, regenerative medicine",
    "Genomics",
    "Geo-information and spatial data analysis",
    "Geographical and positioning technologies, satellites",
    "Global Satellite Navigation System (GNSS) / Services & Applications",
    "Hardware technology (RFID, chips, sensors, networking, etc.)",
    "Health data",
    "Health promotion",
    "Health sciences",
    "Health services, health care research",
    "Healthcare system",
    "Heritage preservation",
    "History and Archaeology",
    "Horticulture, viticulture",
    "Human Machine Interface (HMI)",
    "IPR management",
    "In vitro culture of plant material",
    "In-Situ Instruments / sensors",
    "Inclusion",
    "Industrial Automation and Robotics, mechatronics",
    "Industrial bioengineering",
    "Industrial biotechnology",
    "Industrial dynamics",
    "Innovation management",
    "Internet of Things",
    "Investigations of computer crime (cybercrime) and security violations",
    "Irrigation management",
    "Languages and Literature",
    "Law",
    "Local/wide area observation and surveillance",
    "Low emission technology in transport",
    "Machine learning, statistical data processing and applications using signal processing (e.g. speech, image, video)",
    "Manufacturing and Supply Chain",
    "Manufacturing and processing",
    "Marine Biotechnology",
    "Marine Ecosystems Restoration",
    "Marine biodiversity conservation",
    "Marine biorefineries",
    "Marine, Coastal And Ocean Pollution",
    "Maritime transport",
    "Market-creating innovation",
    "Marketing management",
    "Materials engineering",
    "Mathematics",
    "Mechanical engineering",
    "Media and communications",
    "Medical biotechnology",
    "Medical devices",
    "Medical engineering",
    "Medical statistics",
    "Mental health",
    "Metabolism, biological basis of metabolism related disorders",
    "Migration",
    "Mobile devices",
    "Modelling, Databases and Risk Analysis",
    "Nano-technology",
    "Nanotechnology, nano-materials, nano engineering",
    "Nature-based solutions",
    "Neurosciences (including psychophysiology)",
    "New participatory democracy models",
    "Nuclear",
    "Nutrition, Dietetics",
    "Obstetrics and gynaecology",
    "Oncology",
    "Optical engineering, photonics, lasers",
    "Other agricultural sciences",
    "Other engineering and technologies",
    "Other humanities",
    "Other medical sciences",
    "Other natural sciences",
    "Other social sciences",
    "Personalised medicine",
    "Pharmacology and pharmacy",
    "Philosophy, Ethics and Religion",
    "Photonics",
    "Physical sciences",
    "Plant breeding and plant protection",
    "Plastics, Marine Litter and Circular Economy",
    "Political science",
    "Precision agriculture",
    "Production technology, process engineering",
    "Psychology",
    "Public administration innovation",
    "Public health",
    "Public health and epidemiology",
    "Public participation",
    "Public sector innovation",
    "Quantum Technologies (e.g. computing and communication)",
    "Rail infrastructure",
    "Regenerative medicine",
    "Regulatory affairs",
    "Remote Sensing Instruments / Sensors",
    "Remote sensing",
    "Remote sensing: satelliteborne sensors, airborne platforms, radar and lidar systems",
    "Renewable energy sources",
    "Rheumatology",
    "Robotics",
    "Robotics and automatic control",
    "Robotics and autonomous systems",
    "Robotics, Tele-Robotics & Autonomous Systems (RTA)",
    "S5 - Emergency response (Copernicus service)",
    "Safety and Security",
    "Satellite systems and applications",
    "Scientific computing, simulation and modelling tools",
    "Security",
    "Social innovation",
    "Social issues",
    "Social structure, inequalities, social mobility, interethnic relations",
    "Soil improvement",
    "Soil science",
    "Space",
    "Space Situational Awareness",
    "Space technology domain",
    "Sustainable transport",
    "Synthetic biology, chemical biology and new bio-engineering concepts",
    "Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions (pharmacogenomics, gene-based",
    "Technology management",
    "Telecommunications",
    "Tomography",
    "Transportation",
    "UAV (unmanned aerial vehicles)",
    "Urban transport",
    "Vaccines",
    "Veterinary science",
    "Waste",
    "Water management",
    "eHealth"
  ],
  "language": [
    "en"
  ],
  "REFERENCE": [
    "52663814TOPICSen"
  ],
  "callTitle": [
    "Bridging actions 2027"
  ],
  "focusArea": [],
  "startDate": [
    "2026-10-20T00:00:00.000+0000"
  ],
  "DATASOURCE": [
    "SEDIA"
  ],
  "callccm2Id": [
    "52663914"
  ],
  "es_Combine": [
    "1"
  ],
  "identifier": [
    "HORIZON-BRIDGING-2027-02-05"
  ],
  "sortStatus": [
    "1"
  ],
  "typeOfMGAs": [
    "43027849"
  ],
  "es_SortDate": [
    "2026-10-20T00:00:00.000+0000"
  ],
  "latestInfos": [
    "[{\"approvalDate\":\"\",\"lastChangeDate\":\"2026-10-22T18:15:43.780\",\"content\":\"The submission session is now available for: HORIZON-BRIDGING-2027-02-05\"}]"
  ],
  "sepTemplate": [
    "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p><p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>"
  ],
  "supportInfo": [
    "<p><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\" rel=\"noopener noreferrer\" target=\"_blank\">Online Manual</a> is your guide on the procedures from proposal submission to managing your grant.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Horizon Europe Programme Guide</a> contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq?isExactMatch=true&amp;status=0&amp;type=0,1&amp;order=DESC&amp;pageNumber=1&amp;pageSize=50&amp;sortBy=publicationDate\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a> – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.</p><p><a href=\"https://research-and-innovation.ec.europa.eu/contact-us/research-enquiry-service_en\" rel=\"noopener noreferrer\" target=\"_blank\">Research Enquiry Service</a> – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" rel=\"noopener noreferrer\" target=\"_blank\">National Contact Points (NCPs)</a> – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).</p><p><a href=\"https://een.ec.europa.eu/\" rel=\"noopener noreferrer\" target=\"_blank\">Enterprise Europe Network</a> – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" rel=\"noopener noreferrer\" target=\"_blank\">IT Helpdesk</a> – contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p><p><a href=\"https://intellectual-property-helpdesk.ec.europa.eu/index_en\" rel=\"noopener noreferrer\" target=\"_blank\">European IPR Helpdesk</a> assists you on intellectual property issues.</p><p><a href=\"mailto:research@cencenelec.eu\" rel=\"noopener noreferrer\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" rel=\"noopener noreferrer\" target=\"_blank\">ETSI Research Helpdesk</a> – the European Standards Organisations advise you how to tackle standardisation in your project proposal.</p><p><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a> – consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search?order=DESC&amp;pageNumber=1&amp;pageSize=50&amp;sortBy=lastModified&amp;isExactMatch=true&amp;type=ORGANISATION,PERSON&amp;frameworkProgramme=43108390\" rel=\"noopener noreferrer\" target=\"_blank\">Partner Search</a> help you find a partner organisation for your proposal.</p>"
  ],
  "deadlineDate": [
    "2027-01-28T00:00:00.000+0000"
  ],
  "deadlineModel": [
    "single-stage"
  ],
  "esST_FileName": [
    "file.txt"
  ],
  "esST_checksum": [
    "CE44F3F052603D60ED9D7AC8AC3DBBB7F81CA9F2D0A7655BCB48C77E8A7331D8"
  ],
  "typesOfAction": [
    "HORIZON Innovation Actions"
  ],
  "budgetOverview": [
    "{\"budgetYearsColumns\":[\"2027\"],\"budgetTopicActionMap\":{\"115908\":[{\"action\":\"HORIZON-BRIDGING-2027-02-05 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":13,\"minContribution\":0,\"maxContribution\":2500000,\"budgetYearMap\":{\"2027\":\"32500000\"},\"plannedOpeningDate\":\"2026-10-20\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2027-01-28\"]}]}}"
  ],
  "callIdentifier": [
    "HORIZON-BRIDGING-2027-02"
  ],
  "esDA_QueueDate": [
    "2026-10-22T18:31:51.516+0200"
  ],
  "es_ContentType": [
    "text/plain"
  ],
  "descriptionByte": [
    "<p class=\"topicdescriptionkind\">Expected Outcome:</p><p>Project results are expected to contribute to all the following expected outcomes:</p><ul level=\"0\"><li>Research and Innovation (R&amp;I) solutions funded under Horizon Europe Pillar II are further advanced along the innovation pathway towards uptake and deployment in the EU and/or Associated Countries, including their translation into high value products, services, processes or business models, strengthening the capacity of European public and private organisations to use innovative solutions.</li><li>End users<sup>[1]</sup> and market actors actively co-develop and validate highly innovative solutions in real-world settings, ensuring demand-side needs are integrated, helping to de-risk the innovation journey.</li><li>The EU and Associated Countries benefit from accelerated commercialisation, adoption and deployment of Horizon Europe results, thereby reinforcing societal benefits, sustainable competitiveness, resilience and strategic autonomy of the Union.</li></ul><p class=\"topicdescriptionkind\">Scope:</p><p>Projects funded under Horizon Europe’s Pillar II generate a wealth of high potential innovative results. Even though such results are many times successfully translated into used solutions, there is a need to increase the efficiency of the R&amp;I investments and foster more uptake of promising results into innovative solutions. If more results<sup>[2]</sup> were converted into innovative products, processes, services, practices, business models or other novel solutions, they would strongly contribute to European societal benefit, sustainable competitiveness, prosperity, clean transformation, wellbeing or strategic autonomy.</p><p>This topic aims at supporting actions that bring solutions generated by Pillar II closer to production and adoption by testing and validating them in real world settings, taking into consideration societal needs, cultural diversity and responsible innovation.</p><p>Consortia do not necessarily have to include beneficiaries from the previous grant(s) but must own or have access to the knowledge assets, including intellectual property, where relevant, as stipulated in the specific conditions of this topic. Applicants should justify the proposed composition of the consortium and how it brings the necessary expertise and results ownership. Proposals may also build on complementary background results from closely related EU actions or national/regional projects contributing to the same innovation pathway, provided that these complementary results strengthen the market-readiness and deployment potential of the main result of the Horizon Europe project.</p><p>Applicants should evidence that the proposed activities start beyond the laboratory or research environment and should focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market replication under real-world conditions.</p><p>Proposals should focus on innovation activities that cover the later stages of development, including the use of research and technology infrastructures<sup>[3]</sup> where relevant, should cover more than one of the following activities:</p><ul level=\"0\"><li><strong>Validation and Testing activities:</strong> This could include refining or piloting of prototypes through iterative testing, ensuring they meet the required regulatory or other standards before moving forward; testing to gain approval from potential users, or trial in real-world settings, including to understand user preferences and/or optimise outcomes; stress testing for technical feasibility to ensure the robustness of solutions at scale.</li><li><strong>Commercialisation aspects:</strong> This could include activities around regulatory compliance standardisation or certification, development of business or pricing strategies and planning for market entry.</li><li><strong>Scaling and Operations:</strong> This could include activities around large scale validation such as interoperability and/or standardising processes for quality assurance and control; preparations for supply chains and operational readiness; planning for ramping up manufacturing or delivery.</li><li><strong>Stakeholder, User and Market Readiness:</strong> This could include activities that involve engaging users/customers through co-creation and iterative feedback mechanisms to refine products and strategies, and to ensure that the proposed solutions are aligned with industrial and/or societal needs, concerns and expectations.</li><li><strong>Deployment and Investment Bridging</strong>: This could include partnering activities to expands market reach and securing the required investment commitment for the next phase by EU or national deployment programmes or investment funds.</li></ul><p>Proposals should clearly outline which wider impact can be expected if the project succeeds, along with convincing Key Performance Indicators or a similar framework to measure and follow up the project impact. Impacts do not have to be only monetary but can also consist of other kinds of societal benefits and impacts on wellbeing, clean transformation, resilience or strategic autonomy etc. To assess the value for investment, proposals should specify, with metrics where relevant, all the following:</p><ul level=\"0\"><li>Describe the expected scale and significance<sup>[4]</sup> of the identified wider impacts.</li><li>Include a business plan or exploitation strategy (including risks and mitigation) that will be further developed during the project. Proposals should identify the beneficiary(ies) (e.g. industry, company, public authority, etc.) responsible for the scaling-up of the solutions. The exploitation strategy should envisage a first deployment in the EU and/or Associated Countries.</li><li>End users should be represented as a beneficiary within the consortium (and identified in the proposal) to test the feasibility of the solution and to ensure that the innovations developed meet the specific needs and requirements of the demand. To support the expected outcomes of the topic, additional end users beyond the project consortium can be subcontracted for further testing and validation activities.</li></ul><p>The maximum project duration should not exceed 3 years.</p><p>If the activities to be carried out under the proposal are relevant and align with STEP<sup>[5]</sup> eligibility, (i.e. digital and deep tech, clean and resource efficient tech and biotech) proposals should demonstrate how they contribute to either: i) bringing innovative, cutting-edge technologies with strong economic potential to the internal market, or ii) reducing or preventing the Union’s strategic dependencies.</p><p>Where relevant, applicants envisaging to include clinical studies<sup>[6]</sup> should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.</p><p class=\"topicdescriptionkind\">Technology Readiness Level - Technology readiness level expected from completed projects</p><div class=\"eui-u-mt-s\"><p>The starting TRL for proposals based on results generated within a project funded under Cluster 3, 4, 5 or 6 should be TRL 6. For proposals based on results generated within a project funded under Cluster 1 or 2, the proposed activities must start beyond the laboratory or research environment and focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market replication under real-world conditions. In case of proposals that are based on results generated within more than one projects, the Cluster of the primary project -as stated by the applicants in their proposal- will be the Cluster to be considered.</p></div><p class=\"eui-u-font-s\">[1] Within this topic end users can be both public and private entities.</p><p class=\"eui-u-font-s\">[2] The term 'results' means any tangible or intangible effect of a given action, such as data, knowhow or information, whatever its form or nature and whether or not it can be protected, as well as any rights attached to it, including intellectual property rights (patents, copyright, trademarks, etc.).</p><p class=\"eui-u-font-s\">[3] The catalogue of European Strategy Forum on Research Infrastructures (ESFRI) research infrastructures portfolio can be browsed on the ESFRI website: <a href=\"https://ri-portfolio.esfri.eu\">https://ri-portfolio.esfri.eu</a></p><p class=\"eui-u-font-s\">[4] Scale refers to the breadth or magnitude of an innovation's reach (e.g., the number of users, industries, or markets affected); significance refers to its importance or transformative effect (e.g., whether it represents an incremental improvement or a fundamental shift in how a problem is solved or a need is met).</p><p class=\"eui-u-font-s\">[5] <a href=\"https://strategic-technologies.europa.eu/about_en\">https://strategic-technologies.europa.eu/about_en</a></p><p class=\"eui-u-font-s\">[6] A clinical study covers clinical studies/trials/investigations/cohorts and is defined as any systematic prospective or retrospective collection and analysis of health data obtained from individual patients or healthy persons in order to address scientific questions related to the understanding, prevention, diagnosis, monitoring or treatment of a disease, mental illness, or physical condition. It includes but it is not limited to clinical studies as defined by Regulation 536/2014 (on medicinal products), clinical investigation and clinical evaluation as defined by Regulation 2017/745 (on medical devices), performance study and performance evaluation as defined by Regulation 2017/746 (on in-vitro diagnostic medical devices).</p><p>From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS - <a href=\"https://euclinicaltrials.eu\">https://euclinicaltrials.eu</a>). CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data.</p><p>Applicants are encouraged to consider the latest innovations and advances in the clinical trial design and research methods in order to evaluate promising interventions allowing shorter development timings. Applicants are also encouraged to follow the World Health Organization (WHO) guidance for best practices for clinical trials (<a href=\"https://www.who.int/publications/i/item/9789240097711\">https://www.who.int/publications/i/item/9789240097711</a>).</p>"
  ],
  "esDA_IngestDate": [
    "2026-10-22T18:31:51.525+0200"
  ],
  "programmePeriod": [
    "2021 - 2027"
  ],
  "topicConditions": [
    "<div class=\"eui-u-mt-l>\"><h4>General conditions</h4><div><h4>1. Admissibility conditions: Proposal page limit and layout</h4><div class=\"eui-u-mt-s\"><p>Admissibility conditions are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex A</a> and <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex E</a> of the Horizon Europe Work Programme General Annexes.</p><p>Proposal page limits and layout are described in Part B of the Application Form available in the Submission System.</p><p><br></br></p></div></div><div><h4>2. Eligible countries</h4><div class=\"eui-u-mt-s\"><p>Eligible countries are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex B</a> of the Work Programme General Annexes.</p><p>A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Horizon Europe Programme Guide</a>.</p><p><br></br></p></div></div><div><h4>3. Other Eligibility Conditions</h4><div class=\"eui-u-mt-s\"><p>The following additional eligibility criteria apply: consortia may include a maximum of 6 independent eligible entities as participants.</p></div><div class=\"eui-u-mt-s\"><p>The proposals must be based on results generated within a prior multi-beneficiary project funded directly under the Clusters of Pillar II (Clusters 1 to 6), through a Research and Innovation Action (RIA), an Innovation Action (IA) or a Pre-commercial Procurement Action (PCP). Applicants may submit a proposal based on results generated within more than one such projects (from the same or different Clusters of Pillar II), however only one of these projects will be considered as primary. Applicants must explicitly state in their proposal the project concerned (or the primary project concerned in case the proposal is based on results generated within more than one projects), by providing the relevant grant number and acronym as indicated in the Funding &amp; Tenders Portal.</p><p>The project(s) must have been completed before the submission deadline[[The ‘end date’ of the grant must be prior to the submission deadline.]]. Ongoing projects[[Projects that have an ‘end date’ after the submission deadline.]] are not considered eligible. Only projects where the granting authority for the completed project is the Commission or Executive Agency[[This means for example that projects such as the ones funded under a co-funded European Partnership or a joint undertaking are not considered eligible.]] are eligible[[Results generated within projects funded via financial support to third parties are not eligible.]].</p></div><div class=\"eui-u-mt-s\"><p>Proposals must provide evidence[[In case of proposals that are based on results generated within more than one projects, evidence of ownership or access to the knowledge assets, including intellectual property where relevant, must be provided for all these projects.]] that the consortium owns or has access to the knowledge assets, including intellectual property, where relevant. More specifically, proposals must include at least one of the following:</p><ul level=\"0\"><li>Confirmation that at least one of the applicants is the owner or holder of the relevant knowledge assets, including if applicable Intellectual Property Rights (IPR), and possesses the necessary rights to commercialise/use the results, or</li><li>Commitment letter from the owner(s) of the relevant result(s) confirming the owner(s)’ willingness to negotiate fair, reasonable, and non-discriminatory access to the results, including IPR where relevant, for the purpose of future exploitation.</li></ul></div><div class=\"eui-u-mt-s\"><p>In line with the “restriction on control in innovation actions in critical technology areas” delineated in General Annex B of the General Annexes, entities established in an eligible country but which are directly or indirectly controlled by China or by a legal entity established in China are not eligible to participate in the action.</p></div><div class=\"eui-u-mt-s\"><p>Some activities, resulting from this topic, may involve using classified background and/or producing of security sensitive results (EUCI and SEN). Please refer to the related provisions in section B Security — EU classified and sensitive information of the General Annexes.</p></div><div class=\"eui-u-mt-s\"><p>If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).</p></div><div class=\"eui-u-mt-s\"><p>Other eligibility conditions are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex B</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div><div><h4>4. Financial and operational capacity and exclusion</h4><div class=\"eui-u-mt-s\"><p>Financial and operational capacity and exclusion are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex C</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div><div><h4>5a. Evaluation and award: Award criteria, scoring and thresholds</h4><div class=\"eui-u-mt-s\"><p>To allow a faster access to funds for small collaborative consortia, grants under this topic will be funded under a Fast Track to Research and Innovation Procedure (FTRI).</p></div><div class=\"eui-u-mt-s\"><p>Indicative timetable for evaluation and grant agreement signature will be:</p><ul level=\"0\"><li>Information on the outcome of the evaluation: Maximum 4 months from the final date for submission; and</li><li>Indicative date for the signing of grant agreements: Maximum 6 months from the final date for submission.</li></ul></div><div class=\"eui-u-mt-s\"><p>To ensure a balanced project portfolio covering all Clusters of Pillar II (Clusters 1 to 6), grants will be awarded (within available budget) to proposals not only in order of ranking but at least also to those proposals that are the 2 highest ranked within different Clusters targeted[[A proposal is considered to target a Cluster of Pillar II (Cluster 1 to 6), when it is based on results generated within a prior multi-beneficiary project funded directly under that Cluster. In case of proposals that are based on results generated within more than one projects, the Cluster of the primary project -as stated by the applicants in their proposal- will be considered as being the Cluster targeted.]], provided that the proposals attain all thresholds.</p></div><div class=\"eui-u-mt-s\"><p>Eligible proposals submitted under this topic and exceeding all the evaluation thresholds will be awarded a STEP Seal ​​​​​​[[<a href=\"https://strategic-technologies.europa.eu/about/step-seal_en\">https://strategic-technologies.europa.eu/about/step-seal_en</a>]].</p></div><div class=\"eui-u-mt-s\"><p>Award criteria, scoring and thresholds are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex D</a> of the Work Programme General Annexes.</p></div></div><div><h4>5b. Evaluation and award: Submission and evaluation processes</h4><div class=\"eui-u-mt-s\"><p>The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.</p></div><div class=\"eui-u-mt-s\"><p>Submission and evaluation processes are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex F</a> of the Work Programme General Annexes and the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Online Manual</a>.</p></div></div><div><h4>5c. Evaluation and award: Indicative timeline for evaluation and grant agreement</h4><div class=\"eui-u-mt-s\"><p>Indicative timeline for evaluation and grant agreement are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex F</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div><div><h4>6. Legal and financial set-up of the grants</h4><div class=\"eui-u-mt-s\"><p>Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf\"><u>decision</u></a> is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf\"><u>https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf</u></a>]].</p></div><div class=\"eui-u-mt-s\"><p>The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.</p></div><div class=\"eui-u-mt-s\"><p>Legal and financial set-up of the grants are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex G</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div></div><div class=\"eui-u-mt-l\"><h4>Specific conditions</h4> <div class=\"eui-u-mt-s\"><p>Specific conditions are described in the specific topic of the Work Programme.</p><p><br></br></p></div></div><div class=\"eui-u-mt-l\"><div class=\"eui-u-mt-s\">\n</div><h4>Application and evaluation forms and model grant agreement (MGA):</h4> <div class=\"eui-u-mt-s\"><p><strong>Application and evaluation form templates</strong></p><p>Please use the application form that you will find in the Submission System. You can find examples of standard application forms in the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/reference-documents?programmePeriod=2021-2027&amp;frameworkProgramme=43108390\" rel=\"noopener noreferrer\" target=\"_blank\">Reference Documents page</a>.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-ria-ia_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Standard evaluation form (HE RIA, IA)</a> - will be used with the necessary adaptations</p><p><strong>Guidance</strong></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Programme Guide</a> </p><p><strong>Model Grant Agreements (MGA)</strong></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/ls-mga_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Lump Sum MGA</a> </p><p><strong>Call-specific instructions</strong> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx\" rel=\"noopener noreferrer\" target=\"_blank\">Information on clinical studies (HE)</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/temp-form/af/detailed-budget-table_he-ls-euratom_en.xlsm\" rel=\"noopener noreferrer\" target=\"_blank\">Detailed budget table (HE LS)</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-funding-what-do-i-need-to-know_he_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Guidance: \"Lump sums - what do I need to know?\"</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/temp-form/af/ownership-control-declaration_en.docx\" rel=\"noopener noreferrer\" target=\"_blank\">Ownership control declaration</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-security-issues-security-section_he_en.docx\" rel=\"noopener noreferrer\" target=\"_blank\">Information on security issues/Security section (HE)</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-security-practitioners_he_en.docx\" rel=\"noopener noreferrer\" target=\"_blank\">Information on security practitioners (HE)</a></p></div><h4>Additional documents:</h4> <div class=\"eui-u-mt-s\"><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-1-general-introduction_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Main Work Programme 2026-2027 – 1. General Introduction</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-14-horizontal-activities_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Main Work Programme 2026-2027 – 14. Horizontal Activities</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Main Work Programme 2026-2027 – 15. General Annexes</a></p><p><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" rel=\"noopener noreferrer\" target=\"_blank\">HE Framework Programme and Rules for Participation Regulation 2021/695</a></p><p><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" rel=\"noopener noreferrer\" target=\"_blank\">HE Specific Programme Decision 2021/764</a></p><p><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=OJ:L_202402509\" rel=\"noopener noreferrer\" target=\"_blank\">EU Financial Regulation 2024/2509</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Decision authorising the use of lump sum contributions under the Horizon Europe Programme</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">EU Grants AGA — Annotated Model Grant Agreement</a></p><p><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal Online Manual</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal Terms and Conditions</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/legalnotice\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal Privacy Statement</a></p></div></div>"
  ],
  "programmeDivision": [
    "43108557",
    "43118846",
    "43118971",
    "43120193",
    "43120821",
    "43121563",
    "43108541",
    "43108390"
  ],
  "specificObjective": [],
  "allowPartnerSearch": [
    "true"
  ],
  "frameworkProgramme": [
    "43108390"
  ],
  "esDA_FirstIngestDate": [
    "2026-09-30T00:16:24.534+0200"
  ],
  "crossCuttingPriorities": [
    "DigitalAgenda",
    "EoscAndFairData",
    "SocInnov",
    "SocietalEngagement",
    "AI",
    "OCEAN"
  ]
}